High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3630-3633

  Reed, Andre L ^a   Califano, Joseph ^a   Cairns, Paul ^a   Westra, William H ^b   Jones, Richard M ^a   Koch, Wayne ^a   Ahrendt, Steven ^b   Eby, Yolanda ^a   Sewell, Duane ^a   Nawroz, Homaira ^a   Bartek, Jiri ^c   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICROSATELLITE DNA; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FRAMESHIFT MUTATION; GENE ACTIVATION; GENE DELETION; GENE LOSS; GENE REARRANGEMENT; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; EXONS; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; METHYLATION; MUTATION;

EID: 9444255067     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boring, C C., Squires, T. S , Tong, T., and Montgomery, S Cancer statistics, 1994. CA Cancer J. Clin., 44: 7-26, 1994.
2. Rice, D. H., and Spiro, G. H Current concepts in head and neck cancer. Am. Cancer Soc., 1: 1-3, 1989.
3. Fearon, E. R., and Vogelstem, B A. Genetic model for colorectal tumongenesis Cell, 61: 759-767, 1990.
4. Weinberg, R. A Oncogenes and tumor suppressor genes. CA Cancer J. Clin., 44: 160-70, 1994.
5. Hollstein, M., Sidransky, D, Vogelstein, B., and Harris, C C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991
6. Boyle, J. O , Hakim, J , Koch, W. van der Riet, P, Hruban, R. H , Roa, R. A., Correo, R., Eby, Y. J , Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
7. Van der Riet, P , Nawroz, H., Hruban, R. H. Corio, R., Tokino, K., Koch, W , and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
8. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J , Liu, Q , Harshman, K., Tavtigian, S. V , Stockert, E., Day, R. S., III, Johnson, B. E , and Skolnick, M. H A cell cycle regulator potentially involved in the genesis of many tumor types Science (Washington DC), 264 436-440, 1994.
9. Nobori, T., Miura, K , Wu, D. J., Lois, A., Takabayashi, K , and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
10. Serrano, M., Hannnon, G. J., and Beach, D. A. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin/cdk4. Nature (Lond.), 366: 704-707, 1993.
11. Serrano, M., Gomez-Lahoz, E, DePinho, R. A., Beach, D., and Bar-Sagi, D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science (Washington DC), 267: 249-252, 1995.
12. Lukas, J., D., Aagaard, L., Mann, D. J , Bartkova, J., Strauss, M., Peters, G., and Bartek, J Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.), 375: 530-506, 1995.
13. Zhang, S-Y., Klein-Szania, A. J. P , Sauter, E. R., Shafarenko, M., Mitsunaga, S , Nobori, T., Carson, D. A., Ridge, J. A., and Goodrow, T. L. Higher frequency of alterations in the p16/cdkn2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54: 5050-5053, 1994.
14. Cairns, P., Mao, A., Lee, D., Schwab., Eby, Y., Tokino, K. van der Riet, P. Blaugrund, J., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss Science (Washington DC), 265: 415-416, 1994.
15. Cairns, P , Ploascik, T. J., Eby, Y, Tokino, K., Califano, J , Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J., Buckler, A., Gabrielson, E., Tockman, M , Cho, K. R , Hedrick, L., Bova G S , William, I., Koch, W., Schwab, D., and Sidransky, D Frequency of homozygous deletion at p16/cdkn2 in primary human tumors. Nat. Genet., 11: 210-212, 1995.
16. Merlo, A., Herman, J. G , Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C , Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/cdkn2/mts1 in human cancers. Nat. Med., 1: 686-692, 1995.
17. Van der Riet, P., Karp, D., Farmer, E , Wei, Q., Grossman, L., Tokino, K., Ruppert, J. M , and Sidransky, D. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res., 54: 25-27, 1994.
18. Reed, J. A., Manahan, L. J., Park, C S., and Brigati, D J. Complete one-hour immunocytochemistry based on capillary action. Biotechniques, 13. 434-443, 1992
19. Gonzalez-Zulueta, M., Bender, C. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/cdkn2 tumour suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
20. Herman, J. G., Graff, J R , Myohanen, S , Nelkin, B D., and Baylin, S. B. MSP, a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci USA, in press, 1996.
21. INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma J. Natl. Cancer Inst., 87: 1870-1875, 1995.
22. INK4 in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res., 55, 6006-6011, 1995.
23. Sakaguchi, M , Fujii, Y , Hirabayashi, H., Yoon, H-E., Komoto, Y., Oue, T , Kusafuka, T., Okada, A., and Matsuda, H. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer, 65 442-445, 1996
24. Caldas, C., Hahn, S. A., da Costa, L T , Redston, M. S., Schutte, M , Seymour, A B , Weinstein, C L , Hruban, R H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994
25. Zhang, X , Xu, H J., Murakami, Y , Sachse, R , Yashima, K , Hirohashi, S , Hu, S. X., Benedict, W F, and Sekiya, T. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma Cancer Res., 54. 4177-4182, 1994.